Gemma Fuster
Overview
Explore the profile of Gemma Fuster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moragas N, Fernandez-Nogueira P, Recalde-Percaz L, Inman J, Lopez-Plana A, Bergholtz H, et al.
Breast Cancer Res
. 2024 Aug;
26(1):122.
PMID: 39138514
Background: A better understanding of ductal carcinoma in situ (DCIS) is urgently needed to identify these preinvasive lesions as distinct clinical entities. Semaphorin 3F (SEMA3F) is a soluble axonal guidance...
2.
Leon X, Valero C, Fuster G, Bragado P, Camacho M, Aviles-Jurado F
Clin Transl Oncol
. 2024 Jun;
27(1):160-165.
PMID: 38898351
Purpose: To analyze the predictive capacity for local disease control of the transcriptional expression of neogenin-1 (NEO1) gene in patients with head and neck squamous cell carcinoma (HNSCC). Methods/patients: A...
3.
Lopez-Aguilar E, Fernandez-Nogueira P, Fuster G, Carbo N, Ciudad C, Noe V
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108234
Therapeutic oligonucleotides are powerful tools for the inhibition of potential targets involved in cancer. We describe the effect of two Polypurine Reverse Hoogsteen (PPRH) hairpins directed against the gene, which...
4.
Meler-Claramonte C, Aviles-Jurado F, Vilaseca I, Terra X, Bragado P, Fuster G, et al.
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565388
The expression of the semaphorin-3F (SEMA3F) and neuropilin-2 (NRP2) is involved in the regulation of lymphangiogenesis. The present study analyzes the relationship between the transcriptional expression of the SEMA3F-NRP2 genes...
5.
Fernandez-Nogueira P, Fuster G, Gutierrez-Uzquiza A, Gascon P, Carbo N, Bragado P
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34201840
Breast cancer (BrCa) is the leading cause of death among women worldwide, with about one million new cases diagnosed each year. In spite of the improvements in diagnosis, early detection...
6.
Repulles J, Terradas M, Fuster G, Genesca A, Anglada T
J Vis Exp
. 2020 Oct;
(163).
PMID: 33044448
Tumorigenesis is a multi-step process in which cells acquire capabilities that allow their growth, survival, and dissemination under hostile conditions. Different tests seek to identify and quantify these hallmarks of...
7.
Fernandez-Nogueira P, Mancino M, Fuster G, Bragado P, Puig M, Gascon P, et al.
J Clin Med
. 2020 Mar;
9(3).
PMID: 32178425
Current evidences state clear that both normal development of breast tissue as well as its malignant progression need many-sided local and systemic communications between epithelial cells and stromal components. During...
8.
Vilaseca I, Fuster G, Aviles-Jurado F
Curr Opin Otolaryngol Head Neck Surg
. 2020 Feb;
28(2):107-111.
PMID: 32022731
Purpose Of Review: A strong association between diabetes mellitus and carcinogenesis has been reported in different organs. The purpose of this review is to summarize the new evidences in relation...
9.
Lopez-Plana A, Fernandez-Nogueira P, Munoz-Guardiola P, Sole-Sanchez S, Megias-Roda E, Perez-Montoyo H, et al.
Int J Cancer
. 2020 Jan;
147(4):1163-1179.
PMID: 31943158
Around 40% of newly diagnosed lung cancer patients are Stage IV, where the improvement of survival and reduction of disease-related adverse events is the main goal for oncologists. In this...
10.
Fernandez-Nogueira P, Mancino M, Fuster G, Lopez-Plana A, Jauregui P, Almendro V, et al.
Clin Cancer Res
. 2019 Nov;
26(6):1432-1448.
PMID: 31699826
Purpose: Despite the therapeutic success of existing HER2-targeted therapies, tumors invariably relapse. This study aimed at identifying new mechanisms responsible for HER2-targeted therapy resistance. Experimental Design: We have used a...